Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association
- PMID: 22556195
- DOI: 10.1161/STR.0b013e3182587839
Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association
Abstract
Purpose: The aim of this guideline is to present current and comprehensive recommendations for the diagnosis and treatment of aneurysmal subarachnoid hemorrhage (aSAH).
Methods: A formal literature search of MEDLINE (November 1, 2006, through May 1, 2010) was performed. Data were synthesized with the use of evidence tables. Writing group members met by teleconference to discuss data-derived recommendations. The American Heart Association Stroke Council's Levels of Evidence grading algorithm was used to grade each recommendation. The guideline draft was reviewed by 7 expert peer reviewers and by the members of the Stroke Council Leadership and Manuscript Oversight Committees. It is intended that this guideline be fully updated every 3 years.
Results: Evidence-based guidelines are presented for the care of patients presenting with aSAH. The focus of the guideline was subdivided into incidence, risk factors, prevention, natural history and outcome, diagnosis, prevention of rebleeding, surgical and endovascular repair of ruptured aneurysms, systems of care, anesthetic management during repair, management of vasospasm and delayed cerebral ischemia, management of hydrocephalus, management of seizures, and management of medical complications.
Conclusions: aSAH is a serious medical condition in which outcome can be dramatically impacted by early, aggressive, expert care. The guidelines offer a framework for goal-directed treatment of the patient with aSAH.
Similar articles
-
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of spontaneous subarachnoid haemorrhage.Stroke Vasc Neurol. 2019 Dec 18;4(4):176-181. doi: 10.1136/svn-2019-000296. eCollection 2019 Dec. Stroke Vasc Neurol. 2019. PMID: 32030200 Free PMC article. Review.
-
Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.Stroke. 2010 Sep;41(9):2108-29. doi: 10.1161/STR.0b013e3181ec611b. Epub 2010 Jul 22. Stroke. 2010. PMID: 20651276 Free PMC article.
-
Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.Stroke. 2009 Mar;40(3):994-1025. doi: 10.1161/STROKEAHA.108.191395. Epub 2009 Jan 22. Stroke. 2009. PMID: 19164800 Review. No abstract available.
-
Methodological assessment of guidelines for the diagnosis and management of cerebral vasospasm using the AGREE-II tool.Neurosurg Focus. 2022 Mar;52(3):E11. doi: 10.3171/2021.12.FOCUS21649. Neurosurg Focus. 2022. PMID: 35231886
-
Current and future treatment considerations in the management of aneurysmal subarachnoid hemorrhage.J Pharm Pract. 2010 Oct;23(5):408-24. doi: 10.1177/0897190010372334. Epub 2010 Aug 12. J Pharm Pract. 2010. PMID: 21507846 Review.
Cited by
-
Extubation timing and risk of extubation failure in aneurysmal subarachnoid hemorrhage patients.Chin Neurosurg J. 2024 Nov 20;10(1):32. doi: 10.1186/s41016-024-00384-1. Chin Neurosurg J. 2024. PMID: 39568022 Free PMC article.
-
Predictors of operative ischemic cerebrovascular complications in skull base tumor resections: Experience in low-resource setting.Neurooncol Pract. 2024 Jul 15;11(6):790-802. doi: 10.1093/nop/npae063. eCollection 2024 Dec. Neurooncol Pract. 2024. PMID: 39554795 Free PMC article.
-
Enteral Cilostazol and High-Dose Intravenous Albumin in Aneurysmal Subarachnoid Hemorrhage Patients With Refractory Cerebral Ischemia.Cureus. 2024 Oct 15;16(10):e71566. doi: 10.7759/cureus.71566. eCollection 2024 Oct. Cureus. 2024. PMID: 39553040 Free PMC article.
-
Soluble Urokinase-Type Plasminogen Activator Receptor and Inflammatory Biomarker Response with Prognostic Significance after Acute Neuronal Injury - a Prospective Cohort Study.Inflammation. 2024 Nov 14. doi: 10.1007/s10753-024-02185-1. Online ahead of print. Inflammation. 2024. PMID: 39540961
-
Admission albumin-globulin ratio associated with delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage.Front Neurol. 2024 Oct 30;15:1438728. doi: 10.3389/fneur.2024.1438728. eCollection 2024. Front Neurol. 2024. PMID: 39539653 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
